ORF Genetics to offer endotoxin- and animal-free FGFb and mLIF for stem cell research
ORF Genetics announced today that the company has added endotoxin- and
animal-free human Fibroblast Growth Factor Basic (FGF basic) and mouse
Leukemia Inhibitory Factor (mouse LIF) to its portfolio of growth
factors for stem cell research.
Founders of ORF Genetics receive recognition from the Association of Chartered Engineers in Iceland
The founders of ORF Genetics were awarded an honorary recognition at the
centennial of the Association of Chartered Engineers in Iceland last
ORF Genetics finalizes a share issue
ORF Genetics in cooperation with Arctica Finance has
finalized a share issue in the amount of ISK 300 million. Fourteen
domestic and foreign investors participated in the share issue which was
oversubscribed by 13.7%.
DM Corporation and ORF Genetics to collaborate on protein drugs
An MOU signed during official visit of Mrs. Preneet Kau, Indian Minister of State for External Affairs, to Iceland.
Aiming for production, marketing and sales of protein drugs on the international market